FDA inspection
Cidara Therapeutics, Inc.: FDA inspection ending Nov 16, 2022
FDA inspection 1191983 · Voluntary Action Indicated (VAI) · San Diego, CA
Key facts
| Inspection ID | 1191983 |
|---|---|
| Firm | Cidara Therapeutics, Inc. |
| FEI number | 3011247109 |
| Address | 6310 Nancy Ridge Dr Ste 101 |
| City | San Diego |
| State | CA |
| ZIP | 92121 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Nov 16, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data